Cargando…
Low Use of Standard-of-Care Antiparasitic Drugs and Increased Estimated Outpatient Payments for Treating Schistosomiasis in the United States, 2013–19
Drug utilization and payment estimates for standard-of-care treatment of schistosomiasis have not been reported previously in the United States. This study estimates the utilization of praziquantel (standard-of-care drug) among patients with schistosomiasis and outpatient payments among those who we...
Autores principales: | Joo, Heesoo, Maskery, Brian A., Alpern, Jonathan D., Chancey, Rebecca J., Weinberg, Michelle, Stauffer, William M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Tropical Medicine and Hygiene
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651520/ https://www.ncbi.nlm.nih.gov/pubmed/35995136 http://dx.doi.org/10.4269/ajtmh.22-0254 |
Ejemplares similares
-
Low Treatment Rates of Parasitic Diseases with Standard-of-Care Prescription Drugs in the United States, 2013–2019
por: Joo, Heesoo, et al.
Publicado: (2022) -
The Effect of Drug Pricing on Outpatient Payments and Treatment for Three Soil-Transmitted Helminth Infections in the United States, 2010–2017
por: Joo, Heesoo, et al.
Publicado: (2021) -
Increases in Anti-infective Drug Prices, Subsequent Prescribing, and Outpatient Costs
por: Lee, Junsoo, et al.
Publicado: (2021) -
Pediatric outpatient utilization by differing Medicaid payment models in the United States
por: Canares, Therese L., et al.
Publicado: (2020) -
Antiparasitic Drugs in the United States—Two Roads to High Prices
por: Shahriar, Arman A., et al.
Publicado: (2020)